"我很久没有这样喝酒了":与阿里皮普拉相关的暴饮暴饮的案例报告
Alyssa Falleni1,2, Audrey Abelleira1, Robin Hieber2
1Clinical Pharmacist Practitioner, Veterans Integrated Services Network 1 Clinical Resource Hub, West Haven, Connecticut.
用于抑郁症增强的阿里皮普拉与患者的暴饮暴饮有关. 在停止服用药物后,这种冲动控制问题得到解决,这表明阿里皮普拉和有问题的饮酒行为之间存在联系.
科学领域:
- 精神病学是一个精神病学.
- 神经药理学神经药理学
背景情况:
- 阿里皮普拉是一种非典型的抗精神病药物,用于增强抗抑郁药物治疗.
- 冲动控制问题 (ICP),如博障碍,与阿里皮普拉使用有关.
- 阿里皮普拉对血清激素和多巴胺激素路径的影响在饮酒行为方面产生了不同的结果.
更多相关视频
07:31Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
08:45Modeling Alcohol Consumption in Rodents Using Two-Bottle Choice Home Cage Drinking and Microstructural Analysis
Published on: November 8, 2024
相关概念视频
Binge Eating Disorders
CNS Depressants: Alcohol and Nicotine
Bulimia Nervosa
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antidepressant Drugs: MAOIs and Other Agents
